SaleJul 15, 2026, 10:46 AM
Lipella Pharmaceuticals Sells Assets After Chapter 11 Filing
AI Summary
Lipella Pharmaceuticals Inc. announced it filed for voluntary Chapter 11 bankruptcy on March 30, 2026. Subsequently, on May 14, 2026, the company entered into an Asset Purchase Agreement with XRAIY for the sale of substantially all of its assets. The U.S. Bankruptcy Court approved this sale on June 4, 2026. The company also cautioned that trading in its common stock during the Chapter 11 case is highly speculative and poses substantial risks.
Key Highlights
- Lipella Pharmaceuticals Inc. filed for voluntary Chapter 11 bankruptcy on March 30, 2026.
- The company entered into an Asset Purchase Agreement with XRAIY on May 14, 2026.
- XRAIY agreed to purchase substantially all of Lipella's assets.
- The U.S. Bankruptcy Court for the Western District of Pennsylvania approved the sale on June 4, 2026.
- The company issued a cautionary note regarding highly speculative trading in its common stock during the Chapter 11 case.